Researchers Identify PHIP as Key Dependency in Cancers with SWI/SNF Mutations

Researchers at St. Jude Children’s Research Hospital have identified a critical vulnerability in cancers associated with mutations in the SWI/SNF chromatin-remodeling complex. The study highlights the gene-regulatory protein PHIP as a key dependency in these cancers, which are marked by widespread inactivation of SWI/SNF components. This finding sheds light on potential new avenues for targeted cancer therapies.

The research focuses on cancers driven by mutations in the SWI/SNF complex, a group of proteins involved in regulating DNA structure and gene expression. Scientists discovered that PHIP plays an essential role in supporting the survival and growth of these cancer cells. By identifying PHIP as a crucial factor, the study provides insight into how certain cancers rely on specific molecular mechanisms to thrive when SWI/SNF components are disrupted. Researchers suggest this discovery could inform future therapeutic strategies aimed at exploiting this vulnerability.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

Author

GOAI